News | August 27, 2007

ACS, Aurora Imaging Technology Make Strides Against Breast Cancer

August 28, 2007 - Aurora Imaging Technology Inc. recently announced that the company is a flagship sponsor of the American Cancer Society’s Making Strides Against Breast Cancer walk, a five-mile, noncompetitive walk, set to take place Oct. 14, 2007 in Boston, MA.

The event is the nation’s oldest and largest one-day walk, raising more than $33 million to fight breast cancer since its inception in 1993. In 2006, nearly 40,000 walkers raised $3.2 million.

Making Strides pledges are dedicated to the Society’s life-saving programs of breast cancer research, education, advocacy and patient support. The Society has invested more in breast cancer research grants over time than any other voluntary public health organization; more than $322 million since 1972.

Flagship sponsors for the 2007 event are AstraZeneca, Aurora Imaging Technology, Inc., BlueCross BlueShield of Mass., H.P. Hood, and WeGotSoccer. Media sponsors are 7 News on NBC, CW56 and MAGIC 106.7 FM.

For more information: www.cancer.org/stridesonline and www.auroramri.com

Related Content

Cardiac MRI being performed at the DeBakey Heart Hospital.

Cardiac MRI being performed at the DeBakey Heart Hospital.

Feature | Cardiac Imaging | May 03, 2018 | By Jeff Zagoudis
Magnetic resonance imaging (MRI) for cardiac assessment provides a radiation-free alternative to other commonly used...
The Chalk River nuclear reactor license has been renewed, but will be decommissioned by 2028.

The Chalk River nuclear isotope reactor license has been renewed, but will be decommissioned by 2028. The reactor supplies about 50 percent of the world's supply of Tc99m.

Feature | Nuclear Imaging | April 02, 2018 | Dave Fornell
April 2, 2018 – The Canadian Nuclear Safety Commission (CNSC) announced March 29 that it renewed Canadian Nuclear Lab
A Tc99m SPECT cardiac exam showing myocardial perfusion in the heart.

Technetium-99m is primarily used for the detection of cancer and to assess perfusion defects in the heart caused by heart attacks or other conditions.

Feature | Radiopharmaceuticals and Tracers | February 08, 2018 | Dave Fornell
February 8, 2018 — The U.S.
Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
GE Healthcare SPECT/CT and PET/CT Systems Enhance Personalized Patient Care
News | Nuclear Imaging | June 10, 2017
GE Healthcare showcased positron emission tomography (PET) and single photon emission computed tomography/computed...
advanced visualization
News | Molecular Imaging | June 09, 2017
The Food and Drug Administration (FDA) has cleared syngo.via VB20 for Molecular Imaging (MI) from Siemens Healthineers...
News | SPECT-CT | June 08, 2017
Siemens Healthineers debuts Symbia Intevo Bold at the 2017 annual meeting of the Society of Nuclear Medicine &...
Videos | Nuclear Imaging | April 28, 2017
David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American S
xSPECT Quant technology, SPECT/CT, Symbia Intevo, Siemens Healthineers, RSNA 2016
News | SPECT Imaging | December 06, 2016
December 6, 2016 — At the 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America (
Siemens Healthineers, Symbia Intevo SPECT/CT system, xSPECT Quant, RSNA 2016
Technology | SPECT-CT | October 18, 2016
October 18, 2016 — At the 2016 annual meeting of the Radiological Society of North America (RSNA 2016), Siemens Healt
Overlay Init